iBio (IBIO) Inventory (2021 - 2022)
iBio's (IBIO) quarterly Inventory came in at $3.9 million in Q2 2022, up 14344.44% year-over-year from N/an in Q2 2021, and up 18.79% quarter-over-quarter from $3.3 million in Q1 2022.
Powered by 
Analysis
iBio (IBIO) Inventory (2021 - 2022) Analysis & Trends
iBio (IBIO) has reported Inventory for 2 consecutive years, with $3.9 million the latest figure, recorded in Q2 2022.
- On a quarterly basis, Inventory rose 14344.44% year-over-year to $3.9 million in Q2 2022; TTM through Jun 2022 was $3.9 million, a 14344.44% increase from a year earlier, with the FY2022 full-year figure at $3.9 million, up 14344.44% from the prior year.
- Inventory was $3.9 million for Q2 2022 at iBio, up from $3.3 million in the prior quarter.
- Over five years, Inventory peaked at $3.9 million in Q2 2022 and troughed at $27000.0 in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 6.22 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 1.95 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.77 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 3.08 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 371.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 280.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 2.38 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 142.38 Mn |
| 10 | iBio | 136.32 Mn | 136.32 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | 3.90 Mn |
| Mar 31, 2022 | 3.28 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 587,000.00 |
| Jun 30, 2021 | 27,000.00 |